Glen Harbor Capital Management LLC Has $63.57 Million Stake in Express Scripts (ESRX)

Glen Harbor Capital Management LLC lessened its stake in Express Scripts (NASDAQ:ESRX) by 29.7% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 920,244 shares of the company’s stock after selling 389,232 shares during the quarter. Express Scripts accounts for about 1.4% of Glen Harbor Capital Management LLC’s portfolio, making the stock its 12th largest holding. Glen Harbor Capital Management LLC’s holdings in Express Scripts were worth $63,571,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently modified their holdings of ESRX. Atria Investments LLC increased its stake in shares of Express Scripts by 10.3% in the 4th quarter. Atria Investments LLC now owns 12,340 shares of the company’s stock valued at $921,000 after purchasing an additional 1,157 shares in the last quarter. Schwab Charles Investment Management Inc. increased its stake in shares of Express Scripts by 4.0% in the 4th quarter. Schwab Charles Investment Management Inc. now owns 3,847,820 shares of the company’s stock valued at $286,701,000 after purchasing an additional 147,293 shares in the last quarter. State of Alaska Department of Revenue increased its stake in shares of Express Scripts by 116.1% in the 4th quarter. State of Alaska Department of Revenue now owns 89,451 shares of the company’s stock valued at $6,674,000 after purchasing an additional 48,063 shares in the last quarter. Steward Partners Investment Advisory LLC increased its stake in shares of Express Scripts by 31.2% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 9,691 shares of the company’s stock valued at $723,000 after purchasing an additional 2,307 shares in the last quarter. Finally, First Manhattan Co. increased its stake in shares of Express Scripts by 14.4% in the 4th quarter. First Manhattan Co. now owns 7,157 shares of the company’s stock valued at $534,000 after purchasing an additional 903 shares in the last quarter. 85.82% of the stock is owned by institutional investors and hedge funds.

ESRX stock opened at $75.65 on Monday. The company has a quick ratio of 0.56, a current ratio of 0.69 and a debt-to-equity ratio of 0.81. The company has a market capitalization of $42.49 billion, a PE ratio of 10.01, a P/E/G ratio of 0.95 and a beta of 0.98. Express Scripts has a 1 year low of $55.80 and a 1 year high of $85.07.

Express Scripts (NASDAQ:ESRX) last posted its quarterly earnings results on Wednesday, May 2nd. The company reported $1.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.76 by $0.01. The business had revenue of $24.77 billion during the quarter, compared to analyst estimates of $24.80 billion. Express Scripts had a return on equity of 25.41% and a net margin of 4.59%. The business’s revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the business earned $1.33 earnings per share. equities research analysts predict that Express Scripts will post 9.07 EPS for the current fiscal year.

Several equities analysts recently weighed in on the company. Robert W. Baird set a $92.00 price target on Express Scripts and gave the company a “buy” rating in a research note on Thursday. William Blair lowered Express Scripts from an “outperform” rating to a “market perform” rating in a research note on Thursday, March 8th. BidaskClub lowered Express Scripts from a “buy” rating to a “hold” rating in a research note on Friday, May 4th. ValuEngine lowered Express Scripts from a “buy” rating to a “hold” rating in a research note on Wednesday, May 2nd. Finally, Barclays cut their price objective on Express Scripts from $84.00 to $83.00 and set an “equal weight” rating for the company in a research note on Thursday, May 3rd. Five equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and five have assigned a buy rating to the company’s stock. Express Scripts presently has a consensus rating of “Hold” and a consensus price target of $82.50.

In other news, VP Everett Neville sold 4,895 shares of the company’s stock in a transaction that occurred on Thursday, March 1st. The stock was sold at an average price of $75.26, for a total value of $368,397.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Christine Houston sold 19,889 shares of the company’s stock in a transaction that occurred on Thursday, March 15th. The shares were sold at an average price of $76.69, for a total value of $1,525,287.41. The disclosure for this sale can be found here. 0.79% of the stock is owned by corporate insiders.

Express Scripts Profile

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply